Nurix Therapeutics swings to profit in Q3 2026 with US$673 million revenue
FROM THE WIRE · FINANCE.YAHOO.COM
Nurix Therapeutics reported third quarter 2026 revenue of US$673.06 million and net income of US$549.81 million, with both basic and diluted earnings per share from continuing operations turning positive compared with losses a year earlier. The nine month results to August 31…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishA sustained return to profit can support the valuation, though this is a small-cap result.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Nurix reported Q3 2026 revenue of US$673.06 million.
- 02Net income for the quarter was US$549.81 million.
- 03For the nine months to August 31, 2026, net income was US$373.1 million.
- 04Earnings per share turned positive from losses a year earlier.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets